Lameire NH,Levin A,Kellum JA,Cheung M,Jadoul M,Winkelmayer WC .2021 .Harmonizing acute and chronic kidney disease de nition and classi cation: Report of a kidney disease: Improving global outcomes (KDIGO) consensus conference. Kidney Int, 06(3) : 516-26.
Bikbov B,Purcell CA,Levey SA,Smith M,Abdoli A,Abebe M. GBD .2020 .A systematic analysis for the global burden of disease study 2017. Lancet, 6736(20) : 30045-3.
Hasan M,Sutradhar I,Gupta RD,Sarker M. .2018 .Prevalence of chronic kidney disease in South Asia: A systematic review. BMC Nephrol, 10(1) : 291.
Ahmed J,Azhar S,Haq NU,Hussain S,Stajer A,Urban E .2022 .Awareness of chronic kidney disease, medication, and laboratory investigation among nephrology and urology patients of Quetta, Pakistan. Int J Environ Res Public Health, 19(9) : .
Ye Z,Zhang Q,Li Y,Wang C,Zhang J,Ma X .2016 .High prevalence of Hyperhomocysteinaemia and its association with target organ damage in Chinese patients with chronic kidney disease. Nutrients, 10(10) : 645.
Rehman T,Shabbir MA,Raheem MIU,Manzoor MF,Ahmad N,Liu ZW .1818 .Cysteine and homocysteine as biomarker of various diseases. Food Sci Nutr, 10(9) : 4696-707.
Angelini A,Cappuccilli ML,Magnoni G,Chiocchini ALC,Aiello V,Napoletano A .2021 .The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol, 38(4) : 2021-4.
Friedman AN,Bostom AG,Selhub J,Levey AS,Rosenberg IH .2001 .The kidney and homocysteine metabolism. J Am Soc Nephrol, 2181(10) : 2181-9.
Kim J,Kim H,Roh H,Kwon Y. .2018 .Causes of hyperhomocysteinaemia and its pathological signi cance. Arch Pharm Res, 10(4) : 372-83.
Koklesova L,Mazurakova A,Samec M,Biringer K,Samuel SM,Busselberg D .2021 .Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA J, 10(4) : 477-505.
Moon H,Ko HJ,Kim AS .2020 .Hyperhomocysteinaemia concurrent with metabolic syndrome is independently associated with chronic kidney disease among community-dwelling adults in an urban Korean population. Int J Environ Res Public Health, 10(18) : 6810.
Lamuno DG,Blanco FJA,Fuentes ED,Visa MTF,Conejo MM,Quintana LP .2023 .Hyperhomocysteinaemia in adult patients: A treatable metabolic condition. Nutrients, 10(1) : 135.
Liu PT,Chen JD .2021 .Synergistic association of hyperuricemia and Hyperhomocysteinaemia with chronic kidney disease in middle-aged adults and the elderly population. Medicine (Baltimore), 10(37) : 0000-000000027202.
Sen U,Mishra PK,Tyagi N,Tyagi SC .2010 .Homocysteine to hydrogen sul de or hypertension. Cell Biochem Biophys, 10(2-3) : 49-58.
Thampi P,Stewart BW,Joseph L,Melnyk SB,Hennings LJ,Nagarajan S. .2007 .Dietary homocysteine promotes atherosclerosis in apoe-de cient mice by inducing scavenger receptors expression. Atherosclerosis, 09(2) : 620-9.
Badri S,Vahdat S,Pourfarzam S,Shahraki M,Ataei TG,S TG .2021 .Homocysteine-lowering interventions in chronic kidney disease. J Res Pharm Pract, 75(3) : 21-24.
Cianciolo G,De Pascalis A,Di Lullo L,Ronco C,Zannini C .2017 .Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: Which comes rst?. Cardiorenal Med, 10(4) : 255-66.
Long Y,Nie J .2016 .Homocysteine in renal injury. Kidney Dis, 10(2) : 80-7.
Chen CH,Yeh EL,Chen CC,Huang SC,Huang YC .2017 .Vitamin B-6, independent of homocysteine, is a signi cant factor in relation to in ammatory responses for chronic kidney disease and hemodialysis patients. Biomed Res Int, 10 : 1-8.
Postovitenko KP,Iliuk IA,Shevchuk SV,Bezsmertna GV,Bezsmertnyi O,Kurylenko IV .2017 .Hyperhomocysteinaemia in patients with chronic kidney disease and its relationship with the functional status of the cardiovascular system. Regul Mech Biosyst, 10(2) : 141-51.
Iqbal MP .2006 .Hyperhomocysteinaemia and coronary artery disease in Pakistan. J Pak Med Assoc, 56(6) : 282-5.
Yakub M,Iqbal MP,Iqbal R .2010 .Dietary patterns are associated with Hyperhomocysteinaemia in an urban Pakistani population. J Nutr, 10(7) : 1261-6.
Ansari T,Jami A,Rabbani B,Ghazanfar B,Khalil M,Jamal Q. .2020 .Frequency of elevated plasma homocysteine (Hcy) levels among type 2 Diabetes mellitus (T2DM) patients. Prof Med J, 10 : 635-40.